Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Nasalcrom cleared by FDA as OTC

Jan. 8, 1997

Zeneca describes nonpeptide antagonists of NK2 receptors

Jan. 8, 1997

Improved formulation of Vanceril approved for market

Jan. 7, 1997

Genome Therapeutics and Schering-Plough genomic-based collaboration

Dec. 31, 1996

Heterocyclic tachykinin antagonists revealed by Zeneca

Dec. 31, 1996

New NK1 antagonists from Ciba-Geigy

Dec. 31, 1996

Dual-action compounds with antiasthma activity reported by Kowa

Dec. 30, 1996

Novel antihistamine formulation approved by FDA

Dec. 24, 1996

LIDAK develops drug discovery approach for asthma

Dec. 23, 1996

Boehringer Ingelheim's modified anti-ICAM-1 antibodies for inflammatory disorders

Dec. 23, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Anticancer drug exerts potent HIV antiviral effects
BioWorld Science
A new isoform of proliferating cell nuclear antigen (PCNA) – cancer-associated PCNA (caPCNA) – that is specifically expressed in cancer tissues has been reported....